Treatment options for postmenopausal osteoporosis
Authors Walsh G
Received 23 July 2012
Accepted for publication 23 July 2012
Published 28 August 2012 Volume 2012:8 Pages 367—368
Garry M Walsh
Division of Applied Medicine, School of Medicine and Dentistry, Institute of Medical Sciences, University of Aberdeen, United Kingdom
To serve our readership better, future editions of Therapeutics and Clinical Risk Management will once again feature the Editor’s comments and views on some of the articles published in that issue of the journal.
Bone is a complex tissue that, in addition to protecting vital organs and giving mechanical support for muscles and joints, provides a mineral reservoir essential for calcium homeostasis, together with the microenvironment essential for hematopoiesis. Osteoporosis is the most common metabolic bone disease, with up to a third of postmenopausal women suffering from this increasingly important public health problem. Key characteristics include low bone mineral density with microarchitectural deterioration of bone tissue leading to increased susceptibility to fragility fractures.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]